Luteal Cystic Ovary Disease
(Luteal cysts) |  |
| Luteal cystic ovary disease is characterized by enlarged ovaries with one or more cysts, the walls of which are thicker than those of follicular cysts because of a lining of luteal tissue. Incidence ratios of follicular versus luteal cysts vary greatly due to diagnostic tendencies of individual veterinarians. The apparent incidence of luteal cysts has risen in recent years. Some veterinarians now use a much more liberal definition of luteal cysts, including any variation from the
classical corpus luteum (CL) type structure. This trend is probably a consequence of the commercial availability and widespread acceptance of the prostaglandin (PG) F2
α products in cattle for their luteolytic properties. The incidence pattern is similar to that of follicular cysts. |
| Etiology and Pathogenesis: |
| The basic causes of true luteal cysts are believed to be the same as for follicular cysts. The release of luteinizing hormone (LH) may be somewhat greater than that occurring when follicular cysts develop, and sufficient to initiate luteinization of follicles but inadequate to cause ovulation. Luteal cysts are an extension of follicular cysts such that the nonovulatory follicle is partially luteinized spontaneously or in response to hormonal therapy. |
|  |
| Clinical Findings: |
| Luteal cysts are accompanied by normal conformation and anestrous behavior. Rectal palpation reveals a quiescent uterus characteristic of the luteal phase of the estrous cycle. Luteal cysts are recognized as smooth, fluctuant domes protruding above the surface of the ovary. Usually, they are single structures. Luteal cysts are differentiated from follicular cysts on the basis of palpable characteristics of both the structure and the uterus and, to some extent, on the cow’s
behavior. Progesterone assay and ultrasonography can help differentiate between follicular and luteal cysts, although with either method a final diagnostic decision remains somewhat subjective. On attempts to manually rupture the cystic structure, follicular cysts burst or rupture under minimal pressure while luteal cysts cannot be ruptured with reasonable force. Both types of cysts respond to LH or gonadotropin releasing hormone (GnRH) therapy, but PGF2
α will lyse some luteal cysts and all diestrual CL structures. When applicable, the prostaglandin treatment is preferable to the human chorionic gonadotropin (HCG) or GnRH products due to its much shorter time from administration to estrus and its lower cost. |
| |
| Treatment and Control: |
| The treatment of choice is luteolytic doses of PGF2
α . A normal estrus is expected in 3-5 days. The major limitation of this treatment is the difficulty in accurately estimating the amount of luteal tissue present. If the structure being diagnosed as a luteal cyst is really a developing CL (as discussed above, sometimes called a cystic CL), it may not respond because dairy cows do not become highly responsive to the luteolytic action of PGF2
α until day 8 after estrus. Luteal cysts also respond to HCG and GnRH therapy effective in the treatment of follicular cysts, but the next estrus could occur 5-21 days after treatment. Manual rupture of luteal cysts is not recommended. |
| Preventive measures are the same as for follicular cystic ovary disease (see
Follicular Cystic Ovary Disease: Overview). |
| |
